BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11002521)

  • 1. [Treatment decision in advanced testicular germ cell tumors].
    Salazar Soler R; Montesinos Muñoz J; Maroto Rey P; Villavicencio Mavrich H
    Arch Esp Urol; 2000; 53(6):522-33. PubMed ID: 11002521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rescue chemotherapy in testicular germ cell tumors].
    Salazar Soler R; Maroto Rey P; Solà Rocabert C; López López JJ
    Arch Esp Urol; 2000; 53(6):554-64. PubMed ID: 11002524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy for good risk germ cell tumors.
    McCaffrey JA; Bajorin DF
    Semin Oncol; 1998 Apr; 25(2):186-93. PubMed ID: 9562451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of stage I germ cell tumors of the testis].
    Santomé Couto L; Tabernero Caturla JM; Villavicencio Mavrich H; Valentí Moreno V
    Arch Esp Urol; 2000; 53(6):474-86. PubMed ID: 11002515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
    van Dijk MR; Steyerberg EW; Stenning SP; Dusseldorp E; Habbema JD
    Br J Cancer; 2004 Mar; 90(6):1176-83. PubMed ID: 15026798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testicular germ cell tumors].
    Dourthe LM; Ouachet M; Fizazi K; Droz JP
    Bull Cancer; 1998 Sep; (1 Suppl):26-39. PubMed ID: 9817070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for advanced germ cell tumors.
    Kondagunta GV; Motzer RJ
    J Clin Oncol; 2006 Dec; 24(35):5493-502. PubMed ID: 17158534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
    Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
    Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant chemotherapy of non-seminoma stage I germ cell tumors of the testis].
    Fernández-Ortega A; García del Muro X; Navarro M; Germà Lluch JR
    Arch Esp Urol; 2000; 53(6):487-90. PubMed ID: 11002516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced germ cell tumors in male patients.
    Nahleh Z; Gallardo J; Tabbara IA
    South Med J; 2000 Nov; 93(11):1054-66. PubMed ID: 11095552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
    Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
    Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of advanced germ-cell tumors of the testis.
    Fléchon A; Rivoire M; Droz JP
    Nat Clin Pract Urol; 2008 May; 5(5):262-76. PubMed ID: 18398406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of disseminated germ cell tumors].
    Kimura G; Akimoto M
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1873-90. PubMed ID: 9797810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell tumors of the ovary.
    Pectasides D; Pectasides E; Kassanos D
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
    Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
    Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.